4.3 Letter

miR-155 as a potential target of IL-3 signaling in primary AML cellsa

Journal

LEUKEMIA RESEARCH
Volume 57, Issue -, Pages 57-59

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2017.02.010

Keywords

miR-155; interleukin-3; AML

Funding

  1. National Health and Medical Research Council [626947]
  2. Australian postgraduate award
  3. Robinson Institute Postgraduate Scholarship
  4. Fred Shahin Early-Career Fellowship
  5. Peter Nelson Leukemia Research Fellowship Fund

Ask authors/readers for more resources

miR-155 has emerged as one of the key microRNAs (miRNAs) involved in normal and malignant myelopoiesis, and high expression of this miRNA has been flagged as a strong independent prognostic marker in Acute Myeloid Leukemia (AML). While elevated expression of miR-155 has been associated with FLT3-ITD mutations, other mechanisms which may regulate expression of this miRNA in AML remain largely unknown. Here, we present new evidence that miR-155 may be a prime target of IL-3 signaling in primary AML cells. This finding, together with the increasingly apparent role for miR-155 in oncogenesis, and the upregulation of the IL-3 receptor alpha subunit in AML, lead us to propose this pathway may significantly contribute to the leukemic transformation. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available